Advantage Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$218K Sell
6,409
-344
-5% -$12.5K 0.17% 137
2019
Q2
$278K Sell
6,753
-87
-1% -$3.46K 0.21% 102
2019
Q1
$276K Buy
6,840
+751
+12% +$30.1K 0.22% 91
2018
Q4
$252K Sell
6,089
-2,293
-27% -$95.2K 0.19% 90
2018
Q3
$351K Sell
8,382
-1,336
-14% -$51.4K 0.23% 81
2018
Q2
$335K Sell
9,718
-2,182
-18% -$74.6K 0.25% 80
2018
Q1
$401K Sell
11,900
-828
-7% -$28.5K 0.15% 115
2017
Q4
$437K Sell
12,728
-2,088
-14% -$71.2K 0.14% 120
2017
Q3
$502K Sell
14,816
-1,003
-6% -$32.2K 0.16% 103
2017
Q2
$504K Buy
15,819
+1,618
+11% +$51K 0.18% 100
2017
Q1
$461K Buy
14,201
+237
+2% +$7.47K 0.18% 100
2016
Q4
$430K Buy
13,964
+567
+4% +$17.3K 0.16% 98
2016
Q3
$431K Buy
13,397
+2,512
+23% +$84K 0.16% 92
2016
Q2
$364K Buy
10,885
+1,990
+22% +$63.5K 0.17% 100
2016
Q1
$250K Buy
8,895
+1,817
+26% +$51.9K 0.11% 110
2015
Q4
$217K Sell
7,078
-180
-2% -$5.66K 0.11% 127
2015
Q3
$216K Sell
7,258
-526
-7% -$16.9K 0.12% 116
2015
Q2
$248K Sell
7,784
-1,103
-12% -$35.9K 0.12% 127
2015
Q1
$293K Buy
8,887
+604
+7% +$19.2K 0.17% 114
2014
Q4
$245K Buy
+8,283
New +$238K 0.18% 101

Other funds holding PFE

Advantage Investment Management's PFE Position: Q3 2019 in Review

Advantage Investment Management reduced its Pfizer (PFE) stake by 5.1% in Q3 2019, selling an estimated $12.5K and leaving 6,409 shares worth $218K. The position accounts for 0.17% of the portfolio, ranked #137.

Advantage Investment Management first reported a position in PFE in Q4 2014 and has held it in 20 quarters since. The position peaked at $504K in Q2 2017. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Advantage Investment Management held 6,409 shares of Pfizer worth $218K as of Q3 2019.
  • Advantage Investment Management sold 344 Pfizer shares in Q3 2019, an estimated $12.5K.
  • Pfizer made up 0.17% of Advantage Investment Management's portfolio in Q3 2019, its #137 holding.
  • Advantage Investment Management first reported a position in Pfizer in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Pfizer position peaked at $504K in Q2 2017.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.